Genenta Science S.p.A.

GNTANasdaq Italy Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$32.648 M

$0.68 -3.44%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

23,432,183

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 160 →

#134Atyr PharmaATYR$36.6M
#135Aligos TherapeuticsALGS$34.3M
#136Genenta Science S.p.A.GNTA$32.6M
#137Quince TherapeuticsQNCX$31.5M
#138Cel SciCVM$29.4M

What if Genenta Science S.p.A. were worth as much as…

Open the what-if tool →

Gold $30.3T

$627,872.80

Per share 927,297× higher

Bitcoin $1.72T

$35,668.10

Per share 52,678× higher

Nvidia $5.48T

$113,650.25

Per share 167,849× higher

Or at a round number

$50.0M $100.0M $200.0M $500.0M

Where these numbers come from

Share counts and financials for Genenta Science S.p.A. are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.